Efficacy and safety of Ropivacaine injection in the management of post-operative pain: A comparison of plane block versus wound infiltration for post-operative analgesia in lumbar arthrodesis surgery.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511406-23-00

Acronym

ROPIDOL

Enrollment

111

Registered

2024-12-10

Start date

2025-11-13

Completion date

Unknown

Last updated

2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar arthrodesis

Brief summary

Morphine demand during the 48 hours after surgery

Detailed description

Changes in the VAS scale just after surgery, at 8, 16, 24 and 48 hours after surgery, Changes in SFMPQ at 24 and 48 hours after surgery, Changes in QoR-15 scales at 24 and 48 hours after surgery, Duration of hospitalization after surgery, Number of adverse effects associated with the drug within the first 48 hours after surgery

Interventions

DRUGRopivacaine B. Braun 10 mg/ml injektionsvätska

DRUGlösning

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Morphine demand during the 48 hours after surgery	—

Secondary

Measure	Time frame
Changes in the VAS scale just after surgery, at 8, 16, 24 and 48 hours after surgery, Changes in SFMPQ at 24 and 48 hours after surgery, Changes in QoR-15 scales at 24 and 48 hours after surgery, Duration of hospitalization after surgery, Number of adverse effects associated with the drug within the first 48 hours after surgery	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026